vaccines-gynecologic-oncology-2018-posters

Page 71

Journal of Clinical Immunology and Allergy

ISSN: 2471-304X

E u r o p e a n C o n g r e s s o n

Vaccines & Vaccination

and Gynecologic Oncology

Vaccines & Vaccination and Gynecologic Oncology 2018

O c t o b e r 2 6 - 2 7 , 2 0 1 8

B u d a p e s t , H u n g a r y

ccess to vaccines and their affordability are prime concerns in developing countries. While much has been done to address these

critical determinants of immunization bymulti-lateral agencies, there aremany aspects related to the character and structure of the

industry which are still to be effectively addressed. Chief among these are the non-egalitarian mission of vaccine companies, the oli-

gopolistic character of the industry, lack of focus on vaccines for neglected diseases and pursuit of profit maximization. Compounding

this at the field level are issues related to health system preparedness, delivery infrastructure, program errors, and to some extent the

negative social and religious influence. It is imperative on the vaccine industry to shed its reticence and play a pro-active and egalitarian

role to foster shared value with governments and the society, and thereby make immunization affordable and accessible to all.

Issues in affordability and access to vaccines

and the role of the vaccine industry

Balasubramaniam K V

Indian Immunologicals Ltd, India

Journal of Clinical Immunology and Allergy, Volume: 4

DOI: 10.21767/2471-304X-C2-006

Euro Vaccines 2018